• Issue

    Neuropsychopharmacology Reports: Volume 45, Issue 1

    March 2025

ISSUE INFORMATION

Open Access

Issue Information

  • First Published: 20 December 2024

ORIGINAL ARTICLE

Open Access

Fluoxetine does not influence response to continuous theta burst stimulation in human motor cortex

  • First Published: 07 November 2024
Fluoxetine does not influence response to continuous theta burst stimulation in human motor cortex

cTBS can produce both inhibition and paradoxical facilitation of cortical MEPs. Contrary to the impact of other SSRIs on alternative forms of non-invasive brain stimulation, fluoxetine 20 mg did not modulate the effect of cTBS.

Open Access

The association between benzodiazepine prescriptions and the risk of laxative use in schizophrenia treatment

  • First Published: 07 November 2024
The association between benzodiazepine prescriptions and the risk of laxative use in schizophrenia treatment

The results of univariate and multivariate logistic regression analyses in the laxative and non-laxative groups are shown in graphical abstract. The results of multivariate logistic regression analyses revealed that benzodiazepine prescriptions were significantly higher in the laxative group (OR, 3.059; 95% CI, 1.523–6.144; p = 2.0 × 10−3).

Open Access

Effects of repetitive transcranial magnetic stimulation therapy on weight and lipid metabolism in patients with treatment-resistant depression: A preliminary single-center retrospective cohort study

  • First Published: 09 November 2024
Effects of repetitive transcranial magnetic stimulation therapy on weight and lipid metabolism in patients with treatment-resistant depression: A preliminary single-center retrospective cohort study

This study investigated changes in weight, BMI, and blood test results before and after repetitive transcranial magnetic stimulation (rTMS) treatment in TRD patients.

CASE REPORT

Open Access

Development of cefepime-induced encephalopathy in a patient with depression and rectal cancer: A case report

  • First Published: 13 November 2024
Development of cefepime-induced encephalopathy in a patient with depression and rectal cancer: A case report

A case of cefepime-induced encephalopathy was described. Depression and cancer might be possible occult risk factors for cefepime-induced encephalopathy.

ORIGINAL ARTICLE

Open Access

Orexin concentrations and diurnal variation in the cerebrospinal fluid of intensive care unit patients undergoing aortic surgery with spinal drainage

  • First Published: 14 November 2024
Orexin concentrations and diurnal variation in the cerebrospinal fluid of intensive care unit patients undergoing aortic surgery with spinal drainage

For the first time, cerebrospinal fluid orexin levels were measured in patients undergoing aortic surgery with spinal drainage, requiring ICU admission. Diurnal variations were observed, but there were no consistent periodic changes.

Open Access

NSW cannabis medicines advisory service retrospective enquiry analysis to inform clinical guidance resource development

  • First Published: 17 November 2024
NSW cannabis medicines advisory service retrospective enquiry analysis to inform clinical guidance resource development

This analysis of enquiries to a comprehensive state government funded cannabis medicines advisory service provides complementary real-world data to clinical trials. Advisory service data adds to existing observational data related to patient clinical characteristics, cannabinoid selection, and potential comorbid disease- and drug-interactions. The findings of this study shed light on the information medical practitioners were seeking to inform their clinical decision making about medical cannabis and informed the development of clinical guidance resources.

Open Access

Initial psychotropic prescriptions and symptom associations in first-visit patients with major depressive disorder: A single-center cross-sectional study

  • First Published: 20 November 2024
Initial psychotropic prescriptions and symptom associations in first-visit patients with major depressive disorder: A single-center cross-sectional study

Among the first-visit patients, 31.4% (118/376) were prescribed antidepressants. Missing educational attainment data and the view of myself domain of the QIDS-J were negatively associated, while the concentration/decision making domain of the QIDS-J was positively associated with antidepressant initiation.

ORIGINAL ARTICLE

Open Access

Current status and features of antipsychotic prescriptions in Japanese forensic psychiatric wards based on a forensic inpatient database

  • First Published: 26 November 2024
Current status and features of antipsychotic prescriptions in Japanese forensic psychiatric wards based on a forensic inpatient database

We analyzed the current status of antipsychotics for Japanese forensic inpatients with schizophrenia spectrum disorders nationwide. Olanzapine was the most commonly prescribed antipsychotic, followed by clozapine. Clozapine was associated with longer hospitalization and a higher rate of seclusion experience.

MICRO REPORT

Open Access

Inhibitory effects of the selective μ-opioid receptor antagonist UD-030 on methamphetamine-induced conditioned place preference

  • First Published: 27 November 2024
Inhibitory effects of the selective μ-opioid receptor antagonist UD-030 on methamphetamine-induced conditioned place preference

Although methamphetamine (METH) and other addictive substance use disorders are a major social problem worldwide, appropriate pharmacotherapies have not yet been discovered. The novel nonpeptidic μ-opioid receptor (MOP)-selective antagonist UD-030 dose-dependently inhibited the acquisition and expression of METH-induced conditioned place preference (CPP) in mice. These results indicate that UD-030 may effectively inhibit rewarding effects of METH and suggest that a novel MOP-selective antagonist may be a candidate for the development of pharmacotherapies for METH addiction.

ORIGINAL ARTICLE

Open Access

Dysregulated HPA axis during postnatal developmental stages in the BTBR T+ Itpr3tf/J mouse: A model of autism spectrum disorder

  • First Published: 28 November 2024
Dysregulated HPA axis during postnatal developmental stages in the BTBR T+ Itpr3tf/J mouse: A model of autism spectrum disorder

During postnatal development, both BTBR T+ Itpr3tf/J (BTBR) mice, a model of autism spectrum disorder (ASD), and control C57BL/6J mice exhibited characteristic changes in basal corticosterone levels, peaking at weaning. At weaning, BTBR mice showed dysregulated stress responses characterized by higher corticosterone and corticotropin-releasing hormone levels but lower adrenocorticotropic hormone levels after acute stress exposure. Additionally, BTBR mice displayed altered expression of glucocorticoid receptor mRNA in specific brain regions, suggesting disrupted hypothalamic–pituitary–adrenal axis function at weaning in this ASD model.

Open Access

Characteristics of psychiatric patients with nightmares after suvorexant administration: A retrospective study

  • First Published: 29 November 2024
Characteristics of psychiatric patients with nightmares after suvorexant administration: A retrospective study

This study investigates the risk factors for nightmares among psychiatric patients treated with suvorexant, an orexin receptor antagonist. A retrospective analysis of 440 patients revealed that 9.1% experienced nightmares, with younger patients (aged 20–39 years) being at a significantly higher risk. These findings suggest age-dependent susceptibility to suvorexant-induced nightmares, highlighting the importance of caution when prescribing this medication to younger individuals.

MICRO REPORT

Open Access

Effects of 3,4-methylenedioxymethamphetamine on neural activity in the nucleus accumbens of male mice engaged in social behavior

  • First Published: 03 December 2024
Effects of 3,4-methylenedioxymethamphetamine on neural activity in the nucleus accumbens of male mice engaged in social behavior

In this study, fiber photometry recordings revealed transient increase in neural activity of the nucleus accumbens (NAc) at the onset of turning toward and sniffing novel mice during the social approach test. 3,4-methylenedioxymethamphetamine (MDMA) administration did not alter NAc neural activity during these social behaviors, whereas it increased social approach time.

ORIGINAL ARTICLE

Open Access

Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms

  • First Published: 04 December 2024
Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms

Subjects with insomnia disorder treated for mild depression or anxiety symptoms from E2006-G000-303, a 12-month, phase 3, randomized, placebo-controlled, double-blind study where subjects were randomized (1:1:1) to placebo, lemborexant 5 mg, or lemborexant 10 mg for 6 months, were evaluated. Lemborexant treatment had a positive effect on sleep in subjects with insomnia disorder treated with medications for depression/anxiety symptoms, with no new safety signals.

Open Access

Effects of short-term exposure to moderate amounts of alcohol on brain volume

  • First Published: 12 December 2024
Effects of short-term exposure to moderate amounts of alcohol on brain volume

This study reveals short-term brain changes from moderate alcohol doses in healthy volunteers. MRI scans show an increase in lateral ventricular volumes and a decrease in specific gray matter regions. These changes suggest acute alterations in CSF dynamics and brain water content, highlighting the need for further research into the underlying biological mechanisms.

Open Access

Association Between Stress-Induced Weight Loss and Autophagy-Related Gene Expression in the Hippocampus and Midbrain of Depression Model Mice

  • First Published: 23 December 2024
Association Between Stress-Induced Weight Loss and Autophagy-Related Gene Expression in the Hippocampus and Midbrain of Depression Model Mice

This study examined the effects of chronic immobilization stress (CIS) on mouse behavior, weight, and autophagy-related gene expression in the hippocampus. In the CIS response group, a correlation analysis was conducted between weight change ratio and Fkbp5 mRNA expression levels, using Pearson's correlation coefficient. Results showed a significant correlation, with significance defined at a p value< 0.05.

MICRO REPORT

Open Access

Administration of a Selective Antagonist for Pituitary Adenylate Cyclase-Activating Polypeptide Receptor in the Hippocampus Causes Anxiolytic Effects in the Male Rat

  • First Published: 26 December 2024
Administration of a Selective Antagonist for Pituitary Adenylate Cyclase-Activating Polypeptide Receptor in the Hippocampus Causes Anxiolytic Effects in the Male Rat

PACAP-6-38, a PAC1R-selective antagonist, was injected into the hippocampus of Sprague–Dawley rats to assess its effect on anxiety-like behavior. The results showed that the drug led to increased time spent in the open arm of the elevated plus-maze, indicating an anxiolytic effect. This suggests that hippocampal PACAP may play a role in promoting anxiety-like behavior.

ORIGINAL ARTICLE

Open Access

Association between psychological distress and schizotypy in adults: A cross-sectional study

  • First Published: 27 December 2024
Association between psychological distress and schizotypy in adults: A cross-sectional study

The present study examined the relationship between psychological distress and schizotypy in a Japanese adult population. The results suggest a strong association between psychological distress and schizotypy.

MICRO REPORT

Open Access

Population Using Tobacco for Pain Relief: A Preliminary Cross-Sectional Study in Japan

  • First Published: 02 January 2025
Population Using Tobacco for Pain Relief: A Preliminary Cross-Sectional Study in Japan

This research reports the results of a preliminary cross-sectional study on tobacco use for pain relief in Japan. The survey found that 6.6% of smokers experiencing pain (8.8% in cases of chronic pain) used tobacco for pain relief. Those who used tobacco for pain relief tended to be younger, more likely to be receiving treatment for schizophrenia and pain, had higher rates of analgesic use, and reported greater pain intensity and catastrophic thinking about pain.

ORIGINAL ARTICLE

Open Access

Biotin Mitigates Alcohol Withdrawal-Induced Anxiety and Depression by Regulating Serotonin Metabolism, BDNF, Inflammation, and Oxidative Stress in Rats

  • First Published: 04 January 2025
Biotin Mitigates Alcohol Withdrawal-Induced Anxiety and Depression by Regulating Serotonin Metabolism, BDNF, Inflammation, and Oxidative Stress in Rats

Biotin has been shown to alleviate anxiety and depression associated with alcohol withdrawal in rats by regulating serotonin metabolism and brain-derived neurotrophic factor levels and reducing inflammation and oxidative stress. This suggests that biotin could serve as a potential therapeutic agent for managing withdrawal symptoms in substance use disorders.

REVIEW ARTICLE

Open Access

Neurobiology of COVID-19-Associated Psychosis/Schizophrenia: Implication of Epidermal Growth Factor Receptor Signaling

  • First Published: 04 January 2025
Neurobiology of COVID-19-Associated Psychosis/Schizophrenia: Implication of Epidermal Growth Factor Receptor Signaling

Coronavirus directly transactivates epidermal growth factor receptors. Coronavirus stimulates epidermal growth factor release by ectodomain shedding. The brain activation of epidermal growth factor receptors results in acute or chronic psychotic behaviors.

Open Access

Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus

  • First Published: 05 January 2025
Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus

This review examines the role of activated platelets in Alzheimer disease (AD) pathology, highlighting their contribution to amyloid peptide (Aβ) accumulation and neurofibrillary tangles. While platelets normally support neuronal health and synaptic plasticity, their overactivation may exacerbate AD. Targeting activated platelets presents a potential strategy to mitigate AD neuropathology.

ORIGINAL ARTICLE

Open Access

Gender Differences in the Effects of Trust on Substance Abuse Severity Among Incarcerated Stimulant Offenders in Japan

  • First Published: 08 January 2025
Gender Differences in the Effects of Trust on Substance Abuse Severity Among Incarcerated Stimulant Offenders in Japan

This study clarified gender differences in the effect of trust on the severity of drug dependence, using data from stimulant offenders imprisoned throughout Japan. Our findings indicate that men's sense of trust in oneself negatively influenced the drug dependence severity; on the other hand, women's distrust in others positively affects the severity of their drug dependence. Thus, it is necessary to consider gender differences when support is provided for stimulant offenders.

MICRO REPORT

Open Access

Co-Expression of Tardive Dyskinesia and Drug-Induced Parkinsonism in Rats Chronically Treated With Haloperidol

  • First Published: 09 January 2025
Co-Expression of Tardive Dyskinesia and Drug-Induced Parkinsonism in Rats Chronically Treated With Haloperidol

Rats chronically treated with haloperidol exhibit drug-induced parkinsonism and tardive dyskinesia. Expression of dynorphin, enkephalin, and dopamine D1 and D2 receptors was altered in haloperidol-treated rats. Both indirect and direct pathways are involved in haloperidol-induced movement disorders.

REVIEW ARTICLE

Open Access

Residual Fatigue in Unipolar and Bipolar Depression: A Systematic Review

  • First Published: 09 January 2025
Residual Fatigue in Unipolar and Bipolar Depression: A Systematic Review

Residual fatigue is a common symptom in patients suffering from depression, impacting quality of life and relapse risk. Modafinil shows promise for short-term relief, but more research, especially in bipolar depression, is vital. Standardized tools are urgently needed.

MICRO REPORT

Open Access

Reliability and Validity of the Japanese Version of the Internet Gaming Disorder Scale for Children (IGDS-C)

  • First Published: 10 January 2025
Reliability and Validity of the Japanese Version of the Internet Gaming Disorder Scale for Children (IGDS-C)

This study assesses the reliability and validity of the Japanese version of the Internet Gaming Disorder Scale for children (IGDS-C) and provides evidence supporting the use of IGDS-C among Japanese clinical and nonclinical populations.

ORIGINAL ARTICLE

Open Access

The Association Between Autism Spectrum Disorders and Dietary Intake of Carbohydrates in School-Aged Children in Iran: A Case–Control Study

  • First Published: 21 January 2025
The Association Between Autism Spectrum Disorders and Dietary Intake of Carbohydrates in School-Aged Children in Iran: A Case–Control Study

This study showed a direct link between autism and the intake of sugar and maltose and an inverse connection between autism and the dietary intake of total carbohydrate, fructose, and lactose.

CASE REPORT

Open Access

Successful Clozapine Treatment for Treatment-Resistant Schizophrenia With Zinc Deficiency Severe Anemia: A Case Report

  • First Published: 21 January 2025
Successful Clozapine Treatment for Treatment-Resistant Schizophrenia With Zinc Deficiency Severe Anemia: A Case Report

A case of severe zinc deficiency anemia after initiation of clozapine. Successful continuation of clozapine treatment with zinc supplementation.

REVIEW ARTICLE

Open Access

Metformin and Cognitive Performance in Patients With Type 2 Diabetes: An Umbrella Review

  • First Published: 27 January 2025
Metformin and Cognitive Performance in Patients With Type 2 Diabetes: An Umbrella Review

Even though metformin shows promise in improving specific cognitive domains, such as memory, and reducing neurodegenerative risks, its effects remain inconsistent across different cognitive assessments. The low quality of existing evidence highlights the need for robust research to determine whether metformin's cognitive impacts are protective, neutral, or dependent on individual patient profiles.

ORIGINAL ARTICLE

Open Access

Association Analysis of Rare CNTN5 Variants With Autism Spectrum Disorder in a Japanese Population

  • First Published: 30 January 2025
Association Analysis of Rare CNTN5 Variants With Autism Spectrum Disorder in a Japanese Population

We investigated the role of rare CNTN5 variants in ASD susceptibility by performing resequencing, genotyping, and association analysis in a Japanese population. Out of three identified CNTN5 rare putatively damaging variants, we found a nominally significant association between the I227 variant and ASD in 614 patients with ASD and 61 058 healthy controls, but not after post hoc correction. Hyperacusis was noted in three out of nine patients carrying the variants.

Open Access

Effects of Psychotropic Medications Taken by Pregnant Women on Newborn Medical Condition and Lactation Method

  • First Published: 30 January 2025
Effects of Psychotropic Medications Taken by Pregnant Women on Newborn Medical Condition and Lactation Method

Psychotropic meds during pregnancy are safe for mothers with psychiatric disorders & their babies. No link to malformations or breastfeeding choice. Birth weight & Apgar scores were tied to gestational weeks, not meds. Larger studies needed.

Open Access

Effectiveness of Attentional Bias Modification Combined With Cognitive Behavioral Therapy in Reducing Relapse Risk and Cravings in Male Patients With Alcohol Use Disorder: A Quasi-Randomized Controlled Trial

  • First Published: 05 February 2025
Effectiveness of Attentional Bias Modification Combined With Cognitive Behavioral Therapy in Reducing Relapse Risk and Cravings in Male Patients With Alcohol Use Disorder: A Quasi-Randomized Controlled Trial

This quasi-randomized controlled trial investigated a novel combined approach of attention bias modification (ABM) with cognitive behavioral therapy (CBT) for male inpatients with alcohol use disorder (AUD). Both the CBT + ABM intervention and CBT-alone groups showed substantial improvements in relapse risk and craving levels over the 6-week treatment period, demonstrating the therapeutic potential of integrating attention retraining with conventional treatment. These findings support the viability of both treatment approaches while suggesting opportunities for future research to optimize combined interventions in naturalistic settings.

Open Access

Gene Expression Signatures of Immaturity, Decreased pH, and Neural Hyperexcitation in the Hippocampus of Alzheimer's Disease Model Mice

  • First Published: 05 February 2025
Gene Expression Signatures of Immaturity, Decreased pH, and Neural Hyperexcitation in the Hippocampus of Alzheimer's Disease Model Mice

Analyses of the 20 gene expression datasets of hippocampus of Alzheimer's disease model mice revealed patterns linked to immaturity, decreased pH, and neural hyperexcitation. Pathway analysis suggests that the gene expression changes might be involved in synaptic and channel functions, as well as inflammatory responses.

Open Access

Gene Expression Profiling in the Cortex of Fabp4 Knockout Mice

  • First Published: 08 February 2025
Gene Expression Profiling in the Cortex of Fabp4 Knockout Mice

This study investigates the role of Fabp4 in brain function using Fabp4 knockout (KO) mice. Despite negligible Fabp4 expression in the brain, RNA-seq analysis revealed significant changes in genes associated with synaptic organization and epigenetic regulation. These findings support the concept of an “adipo-brain axis,” where peripheral metabolic processes influence neural function and behavior.

MICRO REPORT

Open Access

Usefulness of the WAIS-IV Short Form for Measuring Cognitive Function in Patients With Schizophrenia

  • First Published: 12 February 2025
Usefulness of the WAIS-IV Short Form for Measuring Cognitive Function in Patients With Schizophrenia

We developed the WAIS-IV short form for schizophrenia consisting of Similarities and Symbol Search. The short form showed valid IQ estimation and a positive correlation with social functioning confirming the usefulness in clinical application.

ORIGINAL ARTICLE

Open Access

A Longitudinal Study of the Association of Blood Unsaturated Fatty Acids With Posttraumatic Stress Disorder (PTSD)

  • First Published: 17 February 2025
A Longitudinal Study of the Association of Blood Unsaturated Fatty Acids With Posttraumatic Stress Disorder (PTSD)

In this study, we analyzed the relationship between blood fatty acid fractions and PTSD in patients who were treated in the emergency room due to physical trauma. The results showed a relationship between the ω6 unsaturated fatty acids, especially linoleic acid, and PTSD judgment.

REVIEW ARTICLE

Open Access

Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta-Analysis

  • First Published: 27 February 2025
Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta-Analysis

This systematic review examined pharmacological interventions for mild depression; however, no trials were identified that specifically compared antidepressants with placebo exclusively in patients with mild depression. Among supplements, eicosapentaenoic acid and Rhodiola rosea emerged as potential treatment options. The scarcity of high-quality studies highlights the need for further rigorous research to inform evidence-based treatment strategies.

CASE REPORT

Open Access

A Report of Three Cases With Dissociative Disorder: Some Positive Response to Methylphenidate Extended Release Used for Their Concurrent Attention Deficit Hyperactivity Disorder

  • First Published: 21 February 2025
A Report of Three Cases With Dissociative Disorder: Some Positive Response to Methylphenidate Extended Release Used for Their Concurrent Attention Deficit Hyperactivity Disorder

Three cases of dissociative identity disorder with ADHD were described. The use of Methylphenidate improved not only ADHD but also their dissociative symptoms.

ORIGINAL ARTICLE

Open Access

Comparison of Efficacies of a Blonanserin Transdermal Patch and Blonanserin Oral Formulation for Psychiatric Symptoms in Patients With Schizophrenia Treated With Laxatives Using a Japanese Claims Database

  • First Published: 21 February 2025
Comparison of Efficacies of a Blonanserin Transdermal Patch and Blonanserin Oral Formulation for Psychiatric Symptoms in Patients With Schizophrenia Treated With Laxatives Using a Japanese Claims Database

Laxative use has recently been identified as a risk factor for hospitalization in patients with schizophrenia, and oral antipsychotic medication may be problematic due to gastrointestinal dysfunction affecting absorption, suggesting that transdermal antipsychotic patches could be a suitable alternative. A retrospective cohort study compared the efficacies of a blonanserin (BNS) patch and BNS oral formulation in patients with schizophrenia treated with laxatives, with the primary outcome being hospitalization to psychiatric wards. The study found no significant difference in the risk of hospitalization between the BNS patch and BNS oral groups, and further research is warranted to consider factors such as patch preference in the elderly.

Open Access

Epigenetic Clock Analysis for National Institutes of Health Stroke Scale in Patients With Ischemic Stroke

  • First Published: 22 February 2025
Epigenetic Clock Analysis for National Institutes of Health Stroke Scale in Patients With Ischemic Stroke

We conducted epigenetic clock analyses to investigate the association between the difference in NIHSS (dNIHSS) and multiple epigenetic aging in patients with ischemic stroke. There was no significant association in the epigenetic age acceleration. We may be able to find different findings with larger sample size, and longitudinal data such as NIHSS scores at fixed intervals.

Open Access

The Impact of Anhedonia on the Disease Burden of Major Depressive Disorder in the Asia–Pacific Region: A Cross-Sectional Real-World Study

  • First Published: 26 February 2025
The Impact of Anhedonia on the Disease Burden of Major Depressive Disorder in the Asia–Pacific Region: A Cross-Sectional Real-World Study

This cross-sectional, web-based survey study was conducted across Australia, China Mainland, Japan, Malaysia, South Korea, and Taiwan, to assess the impact of anhedonia on the health-related quality of life (HRQoL), health-care resource utilization (HRU), and work productivity in subjects with major depressive disorder (MDD). Multivariate analysis revealed that MDD subjects with anhedonia had significantly worse sexual functioning HRQoL as well as higher HRU and impairment to work productivity and activity than subjects without anhedonia.

CASE REPORT

Open Access

Unwanted Clinical Complications Following the Consumption of Death Coffee: A Case Series

  • First Published: 17 March 2025
Unwanted Clinical Complications Following the Consumption of Death Coffee: A Case Series

Death Coffee” is an incredibly potent brew with caffeine content three times higher than conventional coffees. Caffeine intoxication can occur if caffeinated beverages are consumed in excess.

ORIGINAL ARTICLE

Open Access

Associations Between Cognitive Impairment, Depressive Symptoms, and Work Productivity Loss in Patients With Bipolar Disorder: A Cross-Sectional Analysis

  • First Published: 20 March 2025
Associations Between Cognitive Impairment, Depressive Symptoms, and Work Productivity Loss in Patients With Bipolar Disorder: A Cross-Sectional Analysis

This interim, cross-sectional analysis to evaluate the relationship between cognitive impairment and work productivity loss in patients with bipolar disorder examined correlations among baseline symptom scores and correlations between each symptom score and work productivity loss (presenteeism) and quality of life. Cognitive impairment, depression, and insomnia were associated with both presenteeism and quality of life. The study findings suggest that treatment should focus on improving the core symptoms of bipolar disorder as well as insomnia and cognitive impairment.